BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23201315)

  • 1. Novel polymeric inhibitors of HCoV-NL63.
    Milewska A; Ciejka J; Kaminski K; Karewicz A; Bielska D; Zeglen S; Karolak W; Nowakowska M; Potempa J; Bosch BJ; Pyrc K; Szczubialka K
    Antiviral Res; 2013 Feb; 97(2):112-21. PubMed ID: 23201315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTCC: Broad Range Inhibitor of Coronavirus Entry.
    Milewska A; Kaminski K; Ciejka J; Kosowicz K; Zeglen S; Wojarski J; Nowakowska M; Szczubiałka K; Pyrc K
    PLoS One; 2016; 11(6):e0156552. PubMed ID: 27249425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63.
    Weng JR; Lin CS; Lai HC; Lin YP; Wang CY; Tsai YC; Wu KC; Huang SH; Lin CW
    Virus Res; 2019 Nov; 273():197767. PubMed ID: 31560964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Action of Tryptanthrin Isolated from
    Tsai YC; Lee CL; Yen HR; Chang YS; Lin YP; Huang SH; Lin CW
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32120929
    [No Abstract]   [Full Text] [Related]  

  • 5. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.
    Carbajo-Lozoya J; Ma-Lauer Y; Malešević M; Theuerkorn M; Kahlert V; Prell E; von Brunn B; Muth D; Baumert TF; Drosten C; Fischer G; von Brunn A
    Virus Res; 2014 May; 184():44-53. PubMed ID: 24566223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses.
    Ciejka J; Wolski K; Nowakowska M; Pyrc K; Szczubiałka K
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():735-742. PubMed ID: 28482585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.
    Pyrc K; Bosch BJ; Berkhout B; Jebbink MF; Dijkman R; Rottier P; van der Hoek L
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2000-8. PubMed ID: 16723558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.
    Peters HL; Jochmans D; de Wilde AH; Posthuma CC; Snijder EJ; Neyts J; Seley-Radtke KL
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2923-6. PubMed ID: 26048809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63.
    Horvat M; Avbelj M; Durán-Alonso MB; Banjanac M; Petković H; Iskra J
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human coronavirus NL63: a clinically important virus?
    Fielding BC
    Future Microbiol; 2011 Feb; 6(2):153-9. PubMed ID: 21366416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of infectious human coronavirus NL63.
    Florek D; Burmistrz M; Potempa J; Pyrc K
    J Virol Methods; 2014 Sep; 205():87-90. PubMed ID: 24747590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication-dependent downregulation of cellular angiotensin-converting enzyme 2 protein expression by human coronavirus NL63.
    Dijkman R; Jebbink MF; Deijs M; Milewska A; Pyrc K; Buelow E; van der Bijl A; van der Hoek L
    J Gen Virol; 2012 Sep; 93(Pt 9):1924-1929. PubMed ID: 22718567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children <5 years of age.
    Lee J; Storch GA
    Pediatr Infect Dis J; 2014 Aug; 33(8):814-20. PubMed ID: 24577040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE.
    Jochmans D; Leyssen P; Neyts J
    J Virol Methods; 2012 Aug; 183(2):176-9. PubMed ID: 22575574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies.
    Sastre P; Dijkman R; Camuñas A; Ruiz T; Jebbink MF; van der Hoek L; Vela C; Rueda P
    Clin Vaccine Immunol; 2011 Jan; 18(1):113-8. PubMed ID: 21084464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Croup is associated with the novel coronavirus NL63.
    van der Hoek L; Sure K; Ihorst G; Stang A; Pyrc K; Jebbink MF; Petersen G; Forster J; Berkhout B; Uberla K
    PLoS Med; 2005 Aug; 2(8):e240. PubMed ID: 16104827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design.
    Wang F; Chen C; Tan W; Yang K; Yang H
    Sci Rep; 2016 Mar; 6():22677. PubMed ID: 26948040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations of human coronavirus NL63 infection in children in Taiwan.
    Wu PS; Chang LY; Berkhout B; van der Hoek L; Lu CY; Kao CL; Lee PI; Shao PL; Lee CY; Huang FY; Huang LM
    Eur J Pediatr; 2008 Jan; 167(1):75-80. PubMed ID: 17297612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018.
    Wang Y; Li X; Liu W; Gan M; Zhang L; Wang J; Zhang Z; Zhu A; Li F; Sun J; Zhang G; Zhuang Z; Luo J; Chen D; Qiu S; Zhang L; Xu D; Mok CKP; Zhang F; Zhao J; Zhou R; Zhao J
    Emerg Microbes Infect; 2020; 9(1):246-255. PubMed ID: 31996093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane Protein of Human Coronavirus NL63 Is Responsible for Interaction with the Adhesion Receptor.
    Naskalska A; Dabrowska A; Szczepanski A; Milewska A; Jasik KP; Pyrc K
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.